Phase I pharmacokinetic study of the hypoxic cell sensitizer etanidazole with carboplatin and cyclophosphamide in the treatment of advanced ovarian cancer.
Phase I pharmacokinetic study of the hypoxic cell sensitizer etanidazole with carboplatin and cyclophosphamide in the treatment of advanced ovarian cancer.
复制标题
缺氧细胞增敏剂依他硝唑联合卡铂和环磷酰胺治疗晚期卵巢癌的 I 期药代动力学研究。
DOI：
10.1016/0360-3016(94)90453-7
复制
发表时间：
1994
期刊：
影响因子：
--
通讯作者：
Coleman,CN
中科院分区：
文献类型：
--
作者：
Shulman,LN;Buswell,L;Goodman,H;Muto,M;Berkowitz,R;Teicher,B;Kusumoto,T;Hurwitz,SJ;Kalish,LA;Coleman,CN
